Clinical trial
Neurocognitive Mechanisms of Disulfiram Treatment of Alcohol Use Disorder
NCT02735577 is registered in ClinicalTrials.gov with New York State Psychiatric Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Neurocognitive Mechanisms of Disulfiram Treatment of Alcohol Use Disorder
- Lead sponsor
- New York State Psychiatric Institute
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 31, 2016
- Completion date
- October 16, 2020
- Enrollment
- 7 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alcohol use disorder